Hydroxychloroquine, a drug widely used for lupus and rheumatoid arthritis, recently gained national attention with the publication of several small clinical studies suggesting it may be helpful for COVID-19 patients. As a result, close to 70 clinical trials have been started worldwide to learn more. Dr. Kristin Moffitt, infectious disease expert at Boston Children’s Hospital provides insights into what’s known about the drug, the handful of trials already completed, and its potential for treating patients with COVID-19: [ Ссылка ]
